Search
Cyclophosphamide Treatment Options in United Kingdom
A collection of 244 research studies where Cyclophosphamide is the interventional treatment. These studies are located in the United Kingdom . Cyclophosphamide is used for conditions such as Breast Cancer, Lymphoma and Leukemia.
193 - 204 of 244
Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
Unknown
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Steroids, such as dexamethasone or prednisolone, may help relieve some of the side effects of chemotherapy. It is not yet known which regimen of chemotherapy plus steroid therapy is more effective in treating patients with multiple myeloma.
PURPOSE: Randomized phase III trial to compare the effectiveness of two differen... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/19/2013
Locations: Hammersmith Hospital, London, England
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
Unknown
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is more effective for metastatic cancer of an unknown site of origin.
PURPOSE: Randomized phase III trial to compare the effectiveness of two combination chemotherapy regimens in treating patients who have metastatic cancer of an unknown site of origin.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/19/2013
Locations: Christie Hospital N.H.S. Trust, Manchester, England
Conditions: Carcinoma of Unknown Primary
Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
Unknown
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Colony-stimulating factors such as filgrastim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy.
PURPOSE: Phase I/II trial to study the effectiveness of combining filgrastim with combination chemotherapy in... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/19/2013
Locations: Cheltenham General Hospital, Cheltenham, England +3 locations
Conditions: Lymphoma
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
Unknown
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy after chemotherapy may kill any remaining tumor cells.
PURPOSE: This phase II trial is studying how well giving combination chemotherapy together with or without radiation... Read More
Gender:
ALL
Ages:
3 years and below
Trial Updated:
09/19/2013
Locations: Our Lady's Hospital for Sick Children, Dublin, Not set +20 locations
Conditions: Brain and Central Nervous System Tumors, Neuroblastoma
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
Active Not Recruiting
RATIONALE: Gathering information about how young patients with ependymoma respond to standard combination chemotherapy and learning about the long-term effects of this treatment may help doctors plan better treatment.
PURPOSE: This phase III trial is observing young patients with ependymoma undergoing standard combination chemotherapy.
Gender:
ALL
Ages:
2 years and below
Trial Updated:
09/19/2013
Locations: Birmingham Children's Hospital, Birmingham, England +9 locations
Conditions: Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Long-term Effects Secondary to Cancer Therapy in Children, Ototoxicity
Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
Unknown
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one drug with surgery and radiation therapy may kill more tumor cells. It is not yet known which combination chemotherapy regimen is most effective in treating patients with Ewing's sarcoma.
PURPOSE: Randomized phase III trial to compare various combination chemotherapy regimens plus surgery a... Read More
Gender:
ALL
Ages:
35 years and below
Trial Updated:
09/16/2013
Locations: Royal Victoria Infirmary, Newcastle-upon-Tyne, England
Conditions: Sarcoma
Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
Unknown
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Bone marrow transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more cancer cells.
PURPOSE: Randomized phase III trial to study the effectiveness of chemotherapy and radiation therapy plus bone marrow transplantation in treating patients who have aggressive non-Hodgkin's lympho... Read More
Gender:
ALL
Ages:
Between 15 years and 65 years
Trial Updated:
09/16/2013
Locations: Newcastle Upon Tyne Hospitals NHS Trust, Newcastle-Upon-Tyne, England
Conditions: Lymphoma
High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery
Completed
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is most effective for ovarian epithelial cancer.
PURPOSE: This randomized phase III trial is studying high-dose chemotherapy to see how well it works compared to standard chemotherapy in treating patients with stage III or stage IV ovarian epithelial cancer that has been remo... Read More
Gender:
FEMALE
Ages:
Between 18 years and 65 years
Trial Updated:
09/16/2013
Locations: Sozialmedizinisches Zentrum Ost - Donauspital, Vienna, Not set +16 locations
Conditions: Ovarian Cancer
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Completed
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. It is not yet known if combination chemotherapy plus peripheral stem cell transplantation... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/16/2013
Locations: Sydney Cancer Centre at Royal Prince Alfred Hospital, Sydney, New South Wales +130 locations
Conditions: Lymphoma
Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.
Completed
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving a chemotherapy drug before surgery may shrink the tumor so that it can be removed during surgery.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by surgery in treating infants who have newly diagnosed neuroblastoma.
Gender:
ALL
Ages:
1 year and below
Trial Updated:
09/16/2013
Locations: St. Anna Children's Hospital, Vienna, Not set +10 locations
Conditions: Neuroblastoma
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
Completed
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of different combination chemotherapy regimens in treating infants who have newly diagnosed neuroblastoma.
Gender:
ALL
Ages:
1 year and below
Trial Updated:
09/16/2013
Locations: St. Anna Children's Hospital, Vienna, Not set +11 locations
Conditions: Neuroblastoma
Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma
Completed
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug, and giving them before surgery, may shrink the tumor so that it can be removed during surgery.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by surgery in treating infants who have newly diagnosed neuroblastoma.
Gender:
ALL
Ages:
1 year and below
Trial Updated:
09/16/2013
Locations: St. Anna Children's Hospital, Vienna, Not set +10 locations
Conditions: Neuroblastoma
193 - 204 of 244
